 - Have no limits on prior lines of therapy or may be treatment-naive if in need of palliative RT provided the patient has not received prior anti-programmed cell death protein 1PD-1, anti-programmed cell death 1 ligand 1 PD-L1, or anti-programmed cell death 1 ligand 2 PD-L2 therapy 